Studies on the biochemical basis for the antiviral activities of some nucleoside analogs.
D000241:Adenosine / Q000031:analogs & derivatives; D000256:Adenoviridae / Q000187:drug effects; D000998:Antiviral Agents; D001086:Arabinofuranosyluracil / Q000031:analogs & derivatives; D002460:Cell Line; D004279:DNA, Viral / Q000096:biosynthesis; D006564:Herpesviridae / Q000187:drug effects; D007042:Hypoxanthines / Q000031:analogs & derivatives; D009705:Nucleosides / Q000494:pharmacology / Q000627:therapeutic use*; D009975:Orthomyxoviridae / Q000187:drug effects; D011684:Purine Nucleosides / Q000627:therapeutic use; D012367:RNA, Viral / Q000096:biosynthesis; D012229:Rhinovirus / Q000187:drug effects; D018139:Simplexvirus / Q000187:drug effects / Q000378:metabolism; D013329:Structure-Activity Relationship; D014616:Vaccinia virus / Q000187:drug effects; D014740:Vidarabine / Q000378:metabolism / Q000627:therapeutic use
D000998:Antiviral Agents; D004279:DNA, Viral; D007042:Hypoxanthines; D009705:Nucleosides; D011684:Purine Nucleosides; D012367:RNA, Viral; D001086:Arabinofuranosyluracil; D014740:Vidarabine; D000241:Adenosine